According to the public relations and information center of the Vice-Presidency for science and technology affairs, production of biotechnological medicine with new technology by domestic researchers is a step toward self-efficacy. Several knowledge-based companies are active in this area.

Some of the actions performed by these companies include acquiring technical knowledge, production of medicine, human vaccines and presenting new medications with complicated technologies to fight against diseases and improve the public health of the society.

Masoon Darou is one of the active knowledge-based companies of this field, which has been able to produce different types of monovalent antitoxins and polyvalent cholesteric botulinum, haemophilus influenza vaccine type b with the commercial brand of MAS-HibVAC®  and Clostridium botulinum toxin type A with the commercial brand of ®MASPORT.

Mahboubeh Jenabi, CEO of this company, expressed about the products: today, consumption of canned food is very common in the world. However, it is essential to boil the cans before consumption since lack of this process might put the health of individuals at risk. One of the quick methods to treat these patients is quick administration of antitoxins. Trivalent botulinum antitoxin type A+B+E is one of the products of this company to treat poisoning with various types of clostridium botulinum in cases where there is no way to detect the type of botulinum.

She continued: haemophilus influenzae type b conjugate vaccine with exuberated tetanus toxoid is another product of this company, which is used to prevent dangerous infections caused by Haemophilus influenzae type b bacteria in children aged below five years and other prone individuals, such as bacteremia, acute meningitis of children, epiglitis, osteomyelitis, epidermis and joint infections. However, production of cosmetic products is completely carried out by domestic enterprises.